UAB News, June 17, 2015
Researchers at the University of Alabama at Birmingham continue efforts to find safe and effective HIV-prevention methods with a new study in female U.S. teens.
The latest study to be led by UAB, MTN-023/IPM 030, is a Phase IIa study evaluating the safety and acceptability of a vaginal ring containing an antiretroviral (ARV) drug called dapivirine among teenage girls ages 15-17 in the United States.
Read more here